Trovagene Inc., of San Diego, said it engaged CRO PRA Health Sciences to conduct its phase Ib/II trial of PCM-075, a polo-like kinase 1 inhibitor, in patients with acute myeloid leukemia. Read More
Decibel Therapeutics Inc., of Boston, said it received an undisclosed equity investment from GV, formerly Google Ventures, in which GV will also contribute its technical expertise to Decibel. Read More
Health Canada implemented new regulations to allow the limited import of specific drugs urgently needed in the country that have yet to be authorized by the agency. Read More
The widespread Ebola outbreak in West Africa in 2013 to 2016 drew worldwide attention and assistance to the continent and calls for local and global collaboration to target neglected tropical diseases. Read More
HONG KONG – Facing increased U.S. regulatory scrutiny, India's largest drugmaker, Sun Pharmaceutical Industries Ltd., is outsourcing some of its manufacturing in a deal that provides South Korea's Samsung Biologics Co. Ltd., the biologics manufacturing arm of the Samsung conglomerate, an opportunity to expand its market share. Read More
LONDON – Angle plc has delivered positive results for its live whole cell liquid biopsy in the diagnosis of ovarian cancer and said the technology is now ready for application as the basis of companion diagnostics for use with targeted cancer therapies. Read More
With the annual International Society on Thrombosis and Hemostasis (ISTH) congress about to begin in Berlin, Shire plc disclosed its bid for another try in hemophilia with a candidate from the hopper of Baxalta Inc., acquired for $32 billion last year. Read More
